HD-OPM Archive
Topics › Blood pressure, salt & potassium

Magnesium at 400 mg/day or more for 12+ weeks lowered blood pressure by about 6/4 mmHg

Louis Nervegna · Jan 17, 2025 · ♥ 22 reactions · 4 comments · original Facebook post
Blood pressure, salt & potassiumSupplements & vitamins
AI summary & key facts

Louis shares a summary of an umbrella meta-analysis finding that magnesium supplementation at doses of at least 400 mg/day for 12 weeks or longer significantly reduced blood pressure, mostly in people with metabolic disorders and likely poor magnesium status. Magnesium is not strong enough to be monotherapy for hypertension.

Magnesium supplementation modestly lowers blood pressure, and may offer some cardiovascular benefits.

#magnesiumHD #bloodpressureHD #hypertensionHD

Research cited

Magnesium plays an important role in blood pressure regulation, as demonstrated by its influence on endothelial function, calcium efflux, and oxidative stress. Magnesium deficiency can contribute to endothelial dysfunction, increased oxidative stress, and vascular remodeling, all of which exacerbate hypertension and cardiovascular disease risk. Supplementation with magnesium has been shown to induce vasodilation, decrease vascular tone, and improve blood pressure outcomes. A recent umbrella meta-analyses (PMID: 39280209) found that magnesium doses ≥400 mg/day, administered for a duration of ≥12 weeks, can significantly reduce both systolic and diastolic blood pressure (SBP: -6.38 mmHg; DBP: -3.71 mmHg)​ - mostly in people with previous metabolic disorder (and also likely to have inadequate magnesium status before supplementing).

Mechanistically, magnesium influences nitric oxide production, prostaglandin synthesis, and calcium channel function, which collectively promote vasodilation and attenuate blood pressure increases.

In practice, ensuring sufficient magnesium intake may offer long-term cardiovascular benefits, especially when integrated into a broader strategy (as magnesium alone is not strong enough to function as a “monotherapy” for treating hypertension) targeting endothelial health, oxidative stress reduction, and vascular integrity

No photo description available.
← newer: 'The Cholesterol Deniers' article on the minority who call solder: Weekend warrior and regular exercise cut disease risk simila →